Skip to main content
Log in

The Authors’ Reply

  • Correspondence
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Awad AG, Voruganti LNP. Measuring quality of life in patients with schizophrenia: an update. Pharmacoeconomics 2012; 30 (3): 183–95

    Article  PubMed  Google Scholar 

  2. Riley WT, Pilkonis P, Cella D, on behalf of the PROMIS Cooperative Group. Application of the National Institutes of Health Patient-Reported Outcome Measurement Information System (PROMIS) to Mental Health Research. J Mental Health Pol Econ 2011; 14 (4): 201–8

    Google Scholar 

Download references

Acknowledgements

The authors have no conflicts of interest that are directly relevant to the content of this letter. The opinions expressed are the authors’ own.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Awad, A.G., Voruganti, L.N.P. The Authors’ Reply. PharmacoEconomics 30, 532–533 (2012). https://doi.org/10.2165/11633650-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11633650-000000000-00000

Navigation